Guidelines for the Li–Fraumeni and heritable TP53 -related ... | Li fraumeni syndrome genereviews

Fifty years after the recognition of the Li–Fraumeni syndrome (LFS), our perception of cancers related to germline alterations of TP53 has ...SkiptomaincontentThankyouforvisitingnature.com.YouareusingabrowserversionwithlimitedsupportforCSS.Toobtainthebestexperience,werecommendyouuseamoreuptodatebrowser(orturnoffcompatibilitymodeinInternetExplorer).Inthemeantime,toensurecontinuedsupport,wearedisplayingthesitewithoutstylesandJavaScript.AdvertisementnatureeuropeanjournalofhumangeneticsarticlesarticleGuidelinesfortheLi–FraumeniandheritableTP53-relatedcancersyndromesDownloadPDFSubjectsCancerscreeningRiskfactorsAbstractFiftyyearsaftertherecognitionoftheLi–Fraumenisyndrome(LFS),ourperceptionofcancersrelatedtogermlinealterationsofTP53hasdrasticallychanged:(i)germlineTP53alterationsareoftenidentifiedamongchildrenwithcancers,inparticularsoft-tissuesarcomas,adrenocorticalcarcinomas,centralnervoussystemtumours,oramongadultfemaleswithearlybreastcancers,withoutfamilialhistory.ThisjustifiestheexpansionoftheLFSconcepttoawidercancerpredispositionsyndromedesignatedheritableTP53-relatedcancer(hTP53rc)syndrome;(ii)theinterpretationofgermlineTP53variantsremainschallengingandshouldintegrateepidemiological,phenotypical,bioinformaticsprediction,andfunctionaldata;(iii)thepenetranceofgermlinedisease-causingTP53variantsisvariable,dependingbothonthetypeofvariant(dominant-negativevariantsbeingassociatedwithahighercancerrisk)andonmodifyingfactors;(iv)whole-bodyMRI(WBMRI)allowsearlydetectionoftumoursinvariantcarriersand(v)incancerpatientswithgermlinedisease-causingTP53variants,radiotherapy,andconventionalgenotoxicchemotherapycontributetothedevelopmentofsubsequentprimarytumours.ItiscriticaltoperformTP53testingbeforetheinitiationoftreatmentinordertoavoidincarriers,ifpossible,radiotherapyandgenotoxicchemotherapies.Inchildren,therecommendationsaretoperformclinicalexaminationandabdominalultrasoundevery6months,annualWBMRIandbrainMRIfromthefirstyearoflife,iftheTP53variantisknowntobeassociatedwithchildho

常見健康問答

延伸文章資訊
Trait Document | Li fraumeni syndrome genereviews
Trait Document. PrintSave to PDF. My46 Logo. Trait Profile. Gene Reviews. Li-Fraumeni syndrome. Other Names: SBLA syndrome (Sarcoma, Breast, Leukemia ...
Guidelines for the Li–Fraumeni and heritable TP53 -related ... | Li fraumeni syndrome genereviews
Fifty years after the recognition of the Li–Fraumeni syndrome (LFS), our perception of cancers related to germline alterations of TP53 has ...
Li Fraumeni syndrome | Li fraumeni syndrome genereviews
The core cancers in Li-Fraumeni syndrome (LFS) are early-onset breast cancer, ACC, soft tissue sarcomas, osteosarcomas, and brain tumors. Also seen in LFS ...
Li-Fraumeni syndrome | Li fraumeni syndrome genereviews
Li-Fraumeni syndrome. In: GeneReviews [Internet], Pagon RA, Bird TC, Dolan CR, Stephens K (Eds), University of Washington, Seattle 2010.
Li-Fraumeni syndrome: MedlinePlus Genetics | Li fraumeni syndrome genereviews
Li-Fraumeni syndrome is a rare disorder that greatly increases the risk of developing several types of cancer, particularly in children and young ...
TP53 gene: MedlinePlus Genetics | Li fraumeni syndrome genereviews
TP53 Genetic Test: MedlinePlus Medical Test | Li fraumeni syndrome genereviews
OMIM Entry | Li fraumeni syndrome genereviews
Li-Fraumeni Syndrome | Li fraumeni syndrome genereviews
OMIM Entry | Li fraumeni syndrome genereviews
Li-Fraumeni-like syndrome (LFL) is defined as a proband with any childhood cancer, or a sarcoma, brain tumor, or adrenocortical tumor before the age of 45 years, ...
Li-Fraumeni Syndrome | Li fraumeni syndrome genereviews
Li-Fraumeni Syndrome. Review. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.
Li-Fraumeni Syndrome | Li fraumeni syndrome genereviews
Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood- and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is ≥70% for men and ≥90% for women.